Phase 4 Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a type of heart attack called a non-ST-segment elevation myocardial infarction (a specific kind of heart attack — confirm with trial site if unsure which type applies)
- People who have completed a heart procedure called coronary PCI (a procedure to open blocked heart arteries)
- Men aged 18 or older, or women aged 18 or older who are not able to become pregnant (for example, due to menopause, a hysterectomy, or another medical condition that prevents pregnancy)
- People who are willing and able to sign a written consent form agreeing to take part
- People for whom a special heart CT scan (called a CCTA) can be arranged within 7 days after their PCI procedure
Who may not be able to join:
- People who have received a flu vaccine in the past 6 months
- People who have another vaccine planned within the next 8 weeks, including a COVID-19 booster
- People with a severe allergy to eggs, or who have had an allergic reaction to a flu vaccine in the past
- People who have heart surgery or another PCI procedure planned within the next 8 weeks
- People whose coronary stent is placed in a specific part of the heart artery called the proximal right coronary artery (confirm with trial site)
- People who show signs of a fever or an active infection at the time of the trial
- People who are allergic to any ingredient in the flu vaccine being used in this trial (called Vaxigrip), including egg proteins, neomycin, formaldehyde, or octoxinol
- People whose immune system is weakened — either due to a medical condition or as a result of medication — in a way that may reduce how well a vaccine works for them
- People who are not able to give informed consent
- People who have already taken part in the ELIMINATE trial previously
- People with a non-heart-related condition, such as certain cancers, where a doctor estimates life expectancy to be less than one year
- People for whom the heart CT scan (CCTA) is not medically suitable — for example, those who cannot lie flat, who cannot receive a certain medication used during the scan (glyceryl trinitrate), who have had a serious reaction to contrast dye before, or who have severely reduced kidney function (confirm specific kidney threshold with trial site)
- People who have atrial fibrillation (an irregular heart rhythm condition)
- People with a long-term inflammatory disease that is not well controlled
- People who would not be able to follow the requirements of the trial as planned
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sara Cajander, MD, Region Örebro län
Phone: +46196021042
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The right coronary artery
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.